BSS Ophthalmic Solution in 2026: What's the Current Situation?

If you've been following the BSS Ophthalmic Solution supply situation, you know it's been a bumpy ride. Balanced Salt Solution — the sterile irrigating solution used in virtually every eye surgery — has faced periodic supply constraints that have left patients anxious and surgical centers scrambling. Here's where things stand in 2026.

Is BSS Ophthalmic Solution Still in Shortage?

The short answer: it depends on where you are and who you order from. BSS Ophthalmic Solution is not on a formal FDA shortage list as of early 2026, but intermittent supply tightness persists, particularly for high-volume surgical centers. The fundamental issue hasn't changed — Alcon remains the dominant FDA-approved manufacturer, and the market has fewer suppliers than it did before the FDA's 2008-2009 enforcement actions.

Some surgical centers report consistent access, while others — especially those in rural areas or those relying on a single distributor — continue to experience periodic stockouts. The situation is best described as "manageable but fragile."

Why Has BSS Been Hard to Find?

The roots of the BSS supply challenge go back years:

• FDA enforcement actions (2008-2009): The FDA required unapproved BSS manufacturers to stop production, dramatically reducing the number of suppliers.
• Baxter's exit: Baxter discontinued its balanced salt solution product, calling it "an older niche product."
• Single dominant manufacturer: Alcon Laboratories is now the primary FDA-approved supplier of BSS, meaning any manufacturing hiccup affects the entire market.
• Rising surgical volume: Cataract surgery is one of the most common procedures in the U.S., and the aging population drives increasing demand every year.

For the full history, read: Why Is BSS Ophthalmic Solution So Hard to Find?

How Much Does BSS Cost in 2026?

BSS Ophthalmic Solution pricing has remained relatively stable:

• Standard BSS (15 mL vial): $21 to $42 depending on the supplier and quantity ordered
• BSS Plus (500 mL): Approximately $107 per container

For patients, these costs are typically bundled into the overall surgical facility charges. You won't usually see a separate line item for BSS on your bill — it's part of the surgical supply package. However, if supply constraints drive prices up, those increases can eventually be reflected in overall surgical costs.

For tips on managing costs, see: How to Save Money on BSS Ophthalmic Solution.

Are There New Options in 2026?

The competitive landscape for ophthalmic irrigating solutions has seen some movement:

• BSS Plus remains available from Alcon and is an excellent alternative for procedures lasting longer than 60 minutes.
• Navstel, a balanced salt solution with hypromellose, dextrose, and glutathione, provides another FDA-approved option.
• Endosol Extra is available as an alternative intraocular irrigating solution.

While no major new entrants have entered the market in 2026, the existing alternatives give surgeons more flexibility than they had immediately after the FDA's enforcement actions. For a complete comparison, read: Alternatives to BSS Ophthalmic Solution.

How to Find BSS in Stock Right Now

If you need BSS Ophthalmic Solution — or you're a patient whose surgery depends on it — here are your best options:

1. Use Medfinder: Visit medfinder.com to check real-time availability from suppliers near you.
2. Contact multiple distributors: Don't rely on a single supplier. McKesson, Cardinal Health, and specialty ophthalmic distributors may have different stock levels.
3. Ask about alternatives: Your surgeon can assess whether BSS Plus, Navstel, or Endosol Extra is appropriate for your procedure.
4. Plan ahead: Order well in advance of scheduled surgeries to avoid last-minute scrambles.

For a detailed guide, see: How to Find BSS Ophthalmic Solution in Stock Near You.

Final Thoughts

The BSS Ophthalmic Solution supply situation in 2026 is better than it was at the height of the post-FDA-enforcement period, but it's not fully resolved. The market remains dependent on a small number of manufacturers, and that structural vulnerability means shortages can recur without warning.

As a patient, the most important thing you can do is communicate with your surgical team. Ask about BSS availability before your procedure, understand the alternatives, and use tools like Medfinder to stay informed. Eye surgery is remarkably safe and effective — and with a little advance planning, supply issues don't have to derail your care.